Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Molecular discrimination of responders and nonresponders to anti-TNF alpha therapy in rheumatoid arthritis by etanercept.
Koczan D, Drynda S, Hecker M, Drynda A, Guthke R, Kekow J, Thiesen HJ
Arthritis Res Ther 2008, 10:R50
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept
Suárez-Fariñas M, Shah KR, Haider AS, Krueger JG, Lowes MA
BMC Dermatology 2010, 10:1 (12 February 2010)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

2.


Methodology article    
Integrative modeling of transcriptional regulation in response to antirheumatic therapy
Hecker M, Goertsches RH, Engelmann R, Thiesen HJ, Guthke R
BMC Bioinformatics 2009, 10:262 (24 August 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

3.


Editorial    
Predicting the future of anti-tumor necrosis factor therapy
Verweij CL
Arthritis Research & Therapy 2009, 11:115 (22 June 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

4.


Research article    
Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse
Nguyen CQ, Sharma A, Lee BH, She JX, McIndoe RA, Peck AB
Arthritis Research & Therapy 2009, 11:R56 (20 April 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]

5.


Review    
Transcription profiling of rheumatic diseases
van Baarsen LGM, Bos CL, Pouw Kraan TCTM, Verweij CL
Arthritis Research & Therapy 2009, 11:207 (30 January 2009)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]


This article is also cited by a further 2 articles in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.